Profil
Kelly Sims is currently working as a Director at Shape Therapeutics, Inc. and as a Partner at Thrive Capital Management, LLC.
Previously, Sims worked as a Vice President-San Francisco Division at The Abernathy MacGregor Group, Inc. Sims completed an undergraduate degree at the University of Iowa.
Aktive Positionen von Kelly Sims
| Unternehmen | Position | Beginn |
|---|---|---|
Thrive Capital Management, LLC
Thrive Capital Management, LLC Investment ManagersFinance Thrive Capital seeks investment opportunities in companies located in the United States. The firm focuses on companies operating in the fields of internet, software and technology services. It provides financing for seed and early-stage capital requirements. | Private Equity Investor | 01.06.2022 |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Direktor/Vorstandsmitglied | 26.04.2022 |
Ehemalige bekannte Positionen von Kelly Sims
| Unternehmen | Position | Ende |
|---|---|---|
The Abernathy MacGregor Group, Inc.
The Abernathy MacGregor Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Ausbildung von Kelly Sims
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Abernathy MacGregor Group, Inc.
The Abernathy MacGregor Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrive Capital Management, LLC
Thrive Capital Management, LLC Investment ManagersFinance Thrive Capital seeks investment opportunities in companies located in the United States. The firm focuses on companies operating in the fields of internet, software and technology services. It provides financing for seed and early-stage capital requirements. | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
















